Labshake search

1 - 6 of 6 citations for Dinitrophenyl beta alanyl glycyl glycine since 2020

• Single-cell landscapes of primary glioblastomas and matched organoids and cell lines reveal variable retention of inter- and intra-tumor heterogeneity

  VG LeBlanc, et al., bioRxiv - Cancer Biology 2021

  Quote: ... Mouse anti-Beta Tubulin (STEMCELL Technologies; 1:500); Rabbit anti-Olig2 (PhosphoSolutions ...
• miR126-mediated impaired vascular integrity in Rett syndrome

  Tatsuya Osaki, et al., bioRxiv - Cell Biology 2024

  Quote: ... 100 nM of LDN-193189 (TGF-beta/Smad inhibitor, STEMCELL Technologies), and 100 ng/ml of Doxycycline and cultured for 7 days with dairy medium change ...
• miR126-mediated impaired vascular integrity in Rett syndrome

  Tatsuya Osaki, et al., bioRxiv - Cell Biology 2024

  Quote: ... and 10 uM of SB431542 (Activin/BMP/TGF-beta inhibitor, STEMCELL Technologies)) ...
• Viral-Induced Alternative Splicing of Host Genes Promotes Influenza Replication

  Matthew G Thompson, et al., bioRxiv - Molecular Biology 2020

  Quote: ... pre-warmed media containing 10 ng/ml beta-interferon (STEMCELL Technologies, Cat #78113) was added to cells ...
• Custom-engineered hydrogels for delivery of human iPSC-derived neurons into the injured cervical spinal cord

  V.M. Doulames, et al., bioRxiv - Bioengineering 2023

  Quote: ... The following primary antibodies were used: beta-tubulin III (STEMCELL Technologies 60052; 1:1000), GFAP (Dako GA524 ...
• Custom-engineered hydrogels for delivery of human iPSC-derived neurons into the injured cervical spinal cord

  V.M. Doulames, et al., bioRxiv - Bioengineering 2023

  Quote: ... The samples were then incubated overnight at 4°C with primary antibody (beta-tubulin III 1:500; STEMCELL Technologies 60052) diluted in blocking buffer ...